Russian version English version
Volume 17   Issue 1   Year 2022
Pertsev N.1, Loginov K.1, Lukashev A.2, Vakulenko Yu.2

Stochastic Modeling of Dynamics of the Spread of COVID-19 Infection Taking Into Account the Heterogeneity of Population According To Immunological, Clinical and Epidemiological Criteria

Mathematical Biology & Bioinformatics. 2022;17(1):43-81.

doi: 10.17537/2022.17.43.


  1. Loginov K., Pertsev N. Direct Statistical Modeling of Spread of Epidemic Based On a Stage-Dependent Stochastic Model. Mathematical Biology and Bioinformatics. 2021;16(2):169-200. doi: 10.17537/2021.16.169
  2. Loginov K.K., Pertsev N.V., Topchii V.A. Numerical modeling of the spread of the epidemic based on a stochastic stage-dependent model. In: Tenth All-Russian Scientific and Practical Conference on simulation and its application in science and industry «Simulation. Theory and Practice» (IMMOD-2021): conference proceedings. Eds. A.M. Plotnikov, M.A. Dolmatov, E.P. Smirnova. St. Petersburg, 2021. P. 284-291.
  3. Pertsev N.V., Loginov K.K., Topchii V.A. Analysis of a Stage-Dependent Epidemic Model Based on a Non-Markov Random Process. Journal of Applied and Industrial Mathematics. 2020;14:566-580. doi: 10.33048/sibjim.2020.23.309
  4. Beretta E., Hara T., Ma W., Takeuchi Y. Global asymptotic stability of an SIR epidemic model with distributed time delay. Nonlin. Anal. 2001;47(6):4107-4115. doi: 10.1016/S0362-546X(01)00528-4
  5. Yuan Y., Belair J. Threshold dynamics in an SEIRS model with latency and temporary immunity. J. Math. Biol. 2014;69:875-904. doi: 10.1007/s00285-013-0720-4
  6. Popova A.Y., Andreeva E.E., Babura E.A., Balakhonov S.V., Bashketova N.S., Bulanov M.V., Valeullina N.N., Goryaev D.V., Detkovskaya N.N., Ezhlova E.B., et al. Features of developing SARS-CoV-2 nucleocapsid protein population-based seroprevalence during the first wave of the COVID-19 epidemic in the Russian Federation. Russ. J. Infect. Immun. 2021;11(2):297-323. doi: 10.15789/2220-7619-FOD-1684
  7. Popova A.Y., Smirnov V.S., Ezhlova E.B., Mel’nikova A.A., Samoilova L.V., Lyalina L.V., Semenova E.V., Gurskiy M.A., Aksenova E.A., Arbuzova T.V., et al. Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic. Probl. Virol. 2021;66(4):299-309. doi: 10.36233/0507-4088-54
  8. Cheng C., Zhang D., Dang D., Geng J., Zhu P., Yuan M., Liang R., Yang H., Jin Y., Xie J., et al. The incubation period of COVID-19: a global meta-analysis of 53 studies and a Chinese observation study of 11 545 patients. Infect. Dis. Poverty. 2021;10(119). doi: 10.1186/s40249-021-00901-9
  9. Lu Q.B., Zhang Y., Liu M.J., Zhang H.Y., Jalali N., Zhang A.R., Li J.C., Zhao H., Song Q.Q., Zhao T.S., et al. Epidemiological parameters of COVID-19 and its implication for infectivity among patients in China, 1 January to 11 February 2020. Eurosurveillance. 2020;25(40). doi: 10.2807/1560-7917.ES.2020.25.40.2000250
  10. He X., Lau E.H.Y., Wu P., Deng X., Wang J., Hao X., Lau Y.C., Wong J.Y., Guan Y., Tan X., et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat. Med. 2020;26:672-675. doi: 10.1038/s41591-020-0869-5
  11. Rhee C., Kanjilal S., Baker M., Klompas M. Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation? Clin. Infect. Dis. 2021;72(8):1467-1474. doi: 10.1093/cid/ciaa1249
  12. Cheng H.Y., Jian S.W., Liu D.P., Ng T.C., Huang W.T., Lin H.H. Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset. JAMA Intern. Med. 2020;180(9):1156-1163. doi: 10.1001/jamainternmed.2020.2020
  13. Hall S.M., Landaverde L., Gill C.J., Yee G.M., Sullivan M., Doucette-Stamm L., Landsberg H., Platt J.T., White L., Hamer D.H., et al. Comparison of Anterior Nares Viral Loads in Asymptomatic and Symptomatic Individuals Diagnosed with SARS-CoV-2 in a University Screening Program. Preprint from medRxiv and bioRxiv. 2022. doi: 10.1101/2022.01.12.22269139
  14. Yan D., Zhang X., Chen C., Jiang D., Liu X., Zhou Y., Huang C., Zhou Y., Guan Z., Ding C., et al. Characteristics of Viral Shedding Time in SARS-CoV-2 Infections: A Systematic Review and Meta-Analysis. Front. Public Heal. 2021;9. doi: 10.3389/fpubh.2021.652842
  15. Marschner I.C. Estimating age-specific COVID-19 fatality risk and time to death by comparing population diagnosis and death patterns: Australian data. BMC Med. Res. Methodol. 2021;21(126). doi: 10.1186/s12874-021-01314-w
  16. Phillip P. Salvatore, Lee C.C., Sleweon S., McCormick D.W., Nicolae L., Knipe K., Dixon T., Banta R., Ogle I., Young C., et al. Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July-August 2021. Preprint from medRxiv and bioRxiv. 2021. doi: 10.1101/2021.11.12.21265796
  17. Rahman S., Rahman M.M., Miah M., Begum M.N., Sarmin M., Mahfuz M., Hossain M.E., Rahman M.Z., Chisti M.J., Ahmed T., et al. COVID-19 reinfections among naturally infected and vaccinated individuals. Sci. Rep. 2022;12(1438). doi: 10.1038/s41598-022-05325-5
  18. Logunov D.Y., Dolzhikova I.V., Shcheblyakov D.V., Tukhvatulin A.I., Zubkova O.V., Dzharullaeva A.S., Kovyrshina A.V., Lubenets N.L., Grousova D.M., Erokhova A.S., et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021;397(10275):671-681. doi: 10.1016/S0140-6736(21)00234-8
  19. Lumley S.F., O’Donnell D., Stoesser N.E., Matthews P.C., Howarth A., Hatch S.B., Marsden B.D., Cox S., James T., Warren F., et al. Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers. N. Engl. J. Med. 2021;384:533-540. doi: 10.1056/NEJMoa2034545
  20. Naaber P., Tserel L., Kangro K., Sepp E., Jurjenson V., Adamson A., Haljasmagi L., Rumm A.P., Maruste R., Karner J., et al. Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study. Lancet Reg. Heal. - Eur. 2021;10. Article No. 100208. doi: 10.1016/j.lanepe.2021.100208
  21. Khoury D.S., Cromer D., Reynaldi A., Schlub T.E., Wheatley A.K., Juno J.A., Subbarao K., Kent S.J., Triccas J.A., Davenport M.P. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. 2021;27:1205-1211. doi: 10.1038/s41591-021-01377-8
  22. Cramér H. Matematicheskie metody statistiki. Moscow, 1975. 648 p. (Translation of: Cramér H. Mathematical Methods of Statistics. Princeton University Press, 1946). doi: 10.1515/9781400883868
Table of Contents Original Article
Math. Biol. Bioinf.
doi: 10.17537/2022.17.43
published in Russian

Abstract (rus.)
Abstract (eng.)
Full text (rus., pdf)


  Copyright IMPB RAS © 2005-2024